152 related articles for article (PubMed ID: 29214088)
1. Advanced Alveolar Soft Part Sarcoma Treated with Pazopanib over Three Years.
Shido Y; Matsuyama Y
Case Rep Oncol Med; 2017; 2017():3738562. PubMed ID: 29214088
[TBL] [Abstract][Full Text] [Related]
2. Alveolar soft part sarcoma: progress toward improvement in survival? A population-based study.
Fujiwara T; Nakata E; Kunisada T; Ozaki T; Kawai A
BMC Cancer; 2022 Aug; 22(1):891. PubMed ID: 35971085
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group study.
Urakawa H; Kawai A; Goto T; Hiraga H; Ozaki T; Tsuchiya H; Nakayama R; Naka N; Matsumoto Y; Kobayashi E; Okuma T; Kunisada T; Ando M; Ueda T; Nishida Y
Cancer Sci; 2020 Sep; 111(9):3303-3312. PubMed ID: 32579783
[TBL] [Abstract][Full Text] [Related]
4. A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma.
Kim M; Kim TM; Keam B; Kim YJ; Paeng JC; Moon KC; Kim DW; Heo DS
Oncologist; 2019 Jan; 24(1):20-e29. PubMed ID: 30254189
[TBL] [Abstract][Full Text] [Related]
5. Lingual alveolar soft part sarcoma responsive to pazopanib: A case report.
Yoshihiro T; Tsuchihashi K; Nio K; Arita S; Nakano T; Yasumatsu R; Jiroumaru R; Ariyama H; Kusaba H; Oda Y; Akashi K; Baba E
Medicine (Baltimore); 2017 Nov; 96(44):e8470. PubMed ID: 29095301
[TBL] [Abstract][Full Text] [Related]
6. Metastatic Alveolar Soft Part Sarcoma Responsive to Pazopanib after Progression through Sunitinib and Bevacizumab: Two Cases.
Read WL; Williams F
Case Rep Oncol; 2016; 9(3):639-643. PubMed ID: 27920695
[TBL] [Abstract][Full Text] [Related]
7. [Treatment and prognosis of stage IV alveolar soft part sarcoma].
Zhao J; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):932-6. PubMed ID: 23336381
[TBL] [Abstract][Full Text] [Related]
8. European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic Therapy.
Touati N; Schöffski P; Litière S; Judson I; Sleijfer S; van der Graaf WT; Italiano A; Isambert N; Gil T; Blay JY; Stark D; Brodowicz T; Marréaud S; Gronchi A
Clin Oncol (R Coll Radiol); 2018 Jul; 30(7):448-454. PubMed ID: 29550245
[TBL] [Abstract][Full Text] [Related]
9. Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group.
Malouf GG; Beinse G; Adam J; Mir O; Chamseddine AN; Terrier P; Honore C; Spano JP; Italiano A; Kurtz JE; Coindre JM; Blay JY; Le Cesne A
Oncologist; 2019 Jul; 24(7):980-988. PubMed ID: 30626710
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma: A Review.
Paoluzzi L; Maki RG
JAMA Oncol; 2019 Feb; 5(2):254-260. PubMed ID: 30347044
[TBL] [Abstract][Full Text] [Related]
11. Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma.
Mukaihara K; Tanabe Y; Kubota D; Akaike K; Hayashi T; Mogushi K; Hosoya M; Sato S; Kobayashi E; Okubo T; Kim Y; Kohsaka S; Saito T; Kaneko K; Suehara Y
PLoS One; 2017; 12(9):e0185321. PubMed ID: 28945796
[TBL] [Abstract][Full Text] [Related]
12. Target therapy for metastatic alveolar soft part sarcoma: a retrospective study with 47 cases.
Liu J; Fan Z; Li S; Gao T; Xue R; Bai C; Zhang L; Tan Z; Fang Z
Ann Transl Med; 2020 Nov; 8(22):1493. PubMed ID: 33313238
[TBL] [Abstract][Full Text] [Related]
13. Alveolar soft part sarcoma metastatic to the breast: a case report.
Asano Y; Kashiwagi S; Takada K; Tokimasa S; Takashima T; Ohsawa M; Hirakawa K; Ohira M
BMC Surg; 2019 Mar; 19(1):30. PubMed ID: 30832622
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of advanced alveolar soft part sarcoma with camrelizumab combined with apatinib: a case report.
Xu Z; Zhang Y; Yu YH
Ann Palliat Med; 2021 Jan; 10(1):785-792. PubMed ID: 33545800
[TBL] [Abstract][Full Text] [Related]
15. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution.
Portera CA; Ho V; Patel SR; Hunt KK; Feig BW; Respondek PM; Yasko AW; Benjamin RS; Pollock RE; Pisters PW
Cancer; 2001 Feb; 91(3):585-91. PubMed ID: 11169942
[TBL] [Abstract][Full Text] [Related]
16. Metastatic alveolar soft part sarcoma of the lung: Metastatic alveolar soft part sarcoma of the lung-a morphologic pitfall on cytology and aberrant CD10 expression on histology.
Nambirajan A; Jain D; Malik P; Arava S; Mathur SR
Diagn Cytopathol; 2016 Mar; 44(3):250-4. PubMed ID: 26693959
[TBL] [Abstract][Full Text] [Related]
17. A retrospective analysis of lung metastasis in 64 patients with alveolar soft part sarcoma.
Liu YP; Jin J; Wang WH; Wang SL; Song YW; Fang H; Ren H; Liu XF; Yu ZH; Li YX
Clin Transl Oncol; 2015 Oct; 17(10):803-9. PubMed ID: 26036854
[TBL] [Abstract][Full Text] [Related]
18. Effective treatment of advanced alveolar soft part sarcoma with sunitinib: A case report.
Ye C; Wang J; Li W; Yuan M; Chai Y
Medicine (Baltimore); 2018 Dec; 97(51):e13584. PubMed ID: 30572461
[TBL] [Abstract][Full Text] [Related]
19. Successful Treatment with Pazopanib for Multiple Lung Metastases of Inguinal Epithelioid Sarcoma: A Case Report.
Irimura S; Nishimoto K; Kikuta K; Nakayama R; Susa M; Horiuchi K; Nakamura M; Matsumoto M; Morioka H
Case Rep Oncol; 2015; 8(3):378-84. PubMed ID: 26500539
[TBL] [Abstract][Full Text] [Related]
20. Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series.
Verschoor AJ; Gelderblom H
Clin Sarcoma Res; 2014; 4():14. PubMed ID: 25302110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
